Smith & Nephew (SNNUF) Research & Development (2009 - 2024)
Smith & Nephew (SNNUF) reported Research & Development of -$137.0 million for Q4 2024, up 17.47% on a YoY basis from -$116.6 million in Q1 2024, and up 17.47% quarter-over-quarter from -$166.0 million in Q4 2023.
Smith & Nephew (SNNUF) Research & Development (2009 - 2024) Analysis & Trends
Smith & Nephew has reported Research & Development for 16 years, with the latest figure at -$137.0 million in Q4 2024.
- For the quarter ending Q4 2024, Research & Development rose 17.47% year-over-year to -$137.0 million; the trailing twelve-month figure through Dec 2024 stood at -$648.0 million (up 1.67% YoY), and the FY2025 full-year result was $296.0 million, up 2.42% from the prior year.
- Research & Development for Q4 2024 stood at -$137.0 million, up from -$166.0 million in the prior quarter.
- The five-year high for Research & Development was -$137.0 million in Q4 2024, with the low at -$174.0 million in Q4 2022.
- Historically, Research & Development has averaged -$159.2 million across 5 years, with a median of -$166.0 million in 2023.
- Annual changes were most pronounced in 2020 — Research & Development jumped 49.32% — and 2021, when it fell 15.54%.
- Smith & Nephew's Research & Development stood at -$148.0 million in 2020, then fell by 15.54% to -$171.0 million in 2021, then fell by 1.75% to -$174.0 million in 2022, then climbed by 4.6% to -$166.0 million in 2023, then rose by 17.47% to -$137.0 million in 2024.
- The last three Research & Development figures came in at -$137.0 million (Q4 2024), -$166.0 million (Q4 2023), and -$174.0 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Smith & Nephew | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -137.00 Mn |
| Dec 31, 2023 | -166.00 Mn |
| Dec 31, 2022 | -174.00 Mn |
| Dec 31, 2021 | -171.00 Mn |
| Dec 31, 2020 | -148.00 Mn |
| Dec 31, 2019 | -292.00 Mn |
| Dec 31, 2018 | -246.00 Mn |
| Dec 31, 2017 | -223.00 Mn |
| Dec 31, 2016 | -230.00 Mn |
| Dec 31, 2015 | -222.00 Mn |
| Dec 31, 2014 | -235.00 Mn |
| Sep 30, 2014 | -57.00 Mn |
| Mar 31, 2014 | -58.00 Mn |
| Dec 31, 2013 | -52.00 Mn |
| Mar 31, 2013 | -62.00 Mn |
| Dec 31, 2012 | -46.00 Mn |
| Jun 30, 2012 | -39.00 Mn |
| Mar 31, 2012 | -46.00 Mn |
| Dec 31, 2011 | 126.00 Mn |
| Sep 30, 2011 | -126.00 Mn |